HemosIL ReadiPlasTin - Taiwan Registration 27747d3c75f6eca33624180d36178363
Access comprehensive regulatory information for HemosIL ReadiPlasTin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 27747d3c75f6eca33624180d36178363 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
27747d3c75f6eca33624180d36178363
Ministry of Health Medical Device Import No. 031739
DHA05603173905
Product Details
This product is an in vitro diagnostic thrombin kinase reagent manufactured using recombinant human tissue factors for the quantitative analysis of prothrombin time (PT) and fibrinogen in citrate-treated human plasma. This product is required for use with ACL TOP series analyzers.
B Hematology and pathology devices
B7340 Fibrinogen Confirmation System
Imported from abroad
Dates and Status
Oct 18, 2018
Oct 18, 2028

